224 related articles for article (PubMed ID: 3717101)
1. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma.
Roberts JR; Desai HI; Gillespie CA; Simons FE
Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101
[TBL] [Abstract][Full Text] [Related]
2. Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined.
Laursen LC; Taudorf E; Gnosspelius Y; Gymose E; Weeke B
Eur J Respir Dis; 1985 Feb; 66(2):82-90. PubMed ID: 2578971
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.
Heins M; Kurtin L; Oellerich M; Maes R; Sybrecht GW
Eur Respir J; 1988 Apr; 1(4):306-10. PubMed ID: 3294036
[TBL] [Abstract][Full Text] [Related]
4. Reduction of serum theophylline levels by terbutaline in children with asthma.
Danziger Y; Garty M; Volwitz B; Ilfeld D; Varsano I; Rosenfeld JB
Clin Pharmacol Ther; 1985 Apr; 37(4):469-71. PubMed ID: 3979007
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis.
van der Vet AP; Kreukniet J; van Drost RH; Maes RA; Fokkens JK; Hamelink MJ
Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):558-64. PubMed ID: 2828249
[TBL] [Abstract][Full Text] [Related]
6. Once-daily theophylline in the treatment of nocturnal asthma.
Vilkka V; Brander P; Hakulinen A; Laitinen J; Sahlström K; Aalto E; Silvasti M; Karttunen P
Eur J Clin Pharmacol; 1990; 39(3):241-3. PubMed ID: 2257859
[TBL] [Abstract][Full Text] [Related]
7. Treatment of nocturnal asthma: the role of sustained-release theophylline and oral beta-2-mimetics.
Wilkens JH; Wilkens H; Heins M; Kurtin L; Oellerich M; Sybrecht GW
Chronobiol Int; 1987; 4(3):387-96. PubMed ID: 3315268
[TBL] [Abstract][Full Text] [Related]
8. Slow-release terbutaline and theophylline for the long-term therapy of children with asthma: a Latin square and factorial study of drug effects and interactions.
Chow OK; Fung KP
Pediatrics; 1989 Jul; 84(1):119-25. PubMed ID: 2662130
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal oxygen saturation and body movement in asthmatics treated with controlled-release preparations of theophylline or terbutaline.
Brander PE; Sovijärvi AR; Salmi T; Hakulinen A; Poppius H
Eur J Clin Pharmacol; 1990; 39(2):117-21. PubMed ID: 2253659
[TBL] [Abstract][Full Text] [Related]
10. A comparison of a theophylline-ephedrine combination with terbutaline.
Bush RK; Smith AM; Welling PG; Alcala JC; Lee TP
Ann Allergy; 1978 Jul; 41(1):13-7. PubMed ID: 208429
[TBL] [Abstract][Full Text] [Related]
11. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
12. Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients.
Vandewalker ML; Kray KT; Weber RW; Nelson HS
Chest; 1986 Aug; 90(2):198-203. PubMed ID: 3525022
[TBL] [Abstract][Full Text] [Related]
13. Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?
Bierman CW; Pierson WE; Shapiro GG; Furukawa CT
Am J Med; 1988 Jul; 85(1B):17-20. PubMed ID: 3041822
[TBL] [Abstract][Full Text] [Related]
14. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
[TBL] [Abstract][Full Text] [Related]
15. Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses.
Smith JA; Weber RW; Nelson HS
Chest; 1980 Dec; 78(6):816-8. PubMed ID: 7004798
[TBL] [Abstract][Full Text] [Related]
16. Aerosol formulations of terbutaline and isoproterenol in theophylline-stabilized asthmatic patients.
Pinnas JL; Campbell SC
Chest; 1984 Dec; 86(6):896-900. PubMed ID: 6389034
[TBL] [Abstract][Full Text] [Related]
17. The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment.
Busse WW; Smith A; Bush RK
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):577-82. PubMed ID: 3771949
[TBL] [Abstract][Full Text] [Related]
18. Once-daily sustained-release theophylline reduces diurnal variation in spirometry and symptomatology in adult asthmatics.
Arkinstall WW; Atkins ME; Harrison D; Stewart JH
Am Rev Respir Dis; 1987 Feb; 135(2):316-21. PubMed ID: 3813191
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML
Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence of a generic slow-release theophylline tablet in children.
Kanthawatana S; Ahrens RC; McCubbin M; Bronsky E; Blake K; Hendeles L
J Pediatr; 1994 Dec; 125(6 Pt 1):987-91. PubMed ID: 7996375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
